Soliris (eculizumab) Concentrated Solution for Intravenous Infusion Only, 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only, Manufactured by: Alexion Pharmaceuticals, Inc., Cheshire, CT 06410, NDC 25682-001-01, UPC 3 25682-001-01 6.
Published February 5, 2014 · Recall initiated: November 4, 2013
Summary
FDA records drug Class I recall D-1049-2014, published February 5, 2014 and initiated November 4, 2013. Recalling firm: Alexion Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 21,661 vials; Lot: Lot #: 10001-1, Exp 07/14; 10010A, Exp 10/15. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: Failed the appearance test for the presence of visible particles.
What to do
Voluntary: Firm initiated · E-Mail
Get an email if SOLIRIS has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SOLIRIS
- Manufacturer
- Alexion Pharmaceuticals, Inc.
- Distributor
- Nationwide, Puerto Rico, Jamaica, and Grenada.
- UPC
- 325682001016
- Lot
- Lot #: 10001-1, Exp 07/14; 10010A, Exp 10/15
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASoliris (eculizumab), 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only, Manufactured by: AlexionAugust 13, 2014
- FDAMercuroclear Antiseptic Anesthetic First Aid Helps prevent infection and relieves pain and itching of minorFebruary 5, 2014
- FDAHydravax High Potency Diuretic Weight Loss Solution, Pharmaceutical Grade, 45 capsules per bottle, DietaryFebruary 5, 2014
- FDAeXtenZone capsules, 1 capsule per blister pack, Distributed by: P.M.C. Company, Buena Park, CA 90621, UPC 6February 5, 2014
- FDAHCG (Lyophilized) Stock # 21714, 5000 IUnits-5 mL vial, Compounded by NuVision Pharmacy Dallas, TX 75244February 5, 2014
- FDAMaXtremeZEN capsules, 1 capsule per blister pack, Distributed by: P&A Enterprise, Buena Park, CA 90621, UPC 6February 5, 2014
Questions about this recall
Was Soliris (eculizumab) Concentrated Solution for Intravenous Infusion Only, 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only, Manufactured by: Alexion Pharmaceuticals, Inc., Cheshire, CT 06410, NDC 25682-001-01, UPC 3 25682-001-01 6. recalled?
Yes. FDA published recall D-1049-2014 on February 5, 2014. Reported hazard: Presence of Particulate Matter: Failed the appearance test for the presence of visible particles.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SOLIRIS. UPC: 325682001016.